The biopharma industry has shed tens of thousands over the past few years. This significant churn rate has created a breeding ground for intellectual property (IP) theft, leaving companies vulnerable both as they lose and gain employees. “Any time you have a situation where there are a lot of employees in a position where they…
Pharma researcher charged with theft of trade secrets
A former director of medical and scientific affairs at Merck (NYSE:MRK) faces criminal charges in federal court in New Jersey for allegedly stealing and transmitting trade secrets. Shafat A. Quadri has been released on $100,000 unsecured bond. He was most recently employed at AstraZeneca (NSDQ:AZN). The single count of trade secret theft carries a maximum potential…